A “building block” approach to the new influenza A virus entry inhibitors with reduced cellular toxicities

Influenza A virus (IAV) is a severe worldwide threat to public health and economic development that results in the emergence of drug-resistant or highly virulent strains. Therefore, it is imperative to develop potent anti-IAV drugs with different modes of action to currently available drugs. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dongguo, Li, Fangfang, Wu, Qiuyi, Xie, Xiangkun, Wu, Wenjiao, Wu, Jie, Chen, Qing, Liu, Shuwen, He, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782136/
https://www.ncbi.nlm.nih.gov/pubmed/26952867
http://dx.doi.org/10.1038/srep22790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782136/
https://www.ncbi.nlm.nih.gov/pubmed/26952867
http://dx.doi.org/10.1038/srep22790

Ejemplares similares